000 01324 a2200313 4500
005 20250517030822.0
264 0 _c20150901
008 201509s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2015.61.4172
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAwad, Mark M
245 0 0 _aDurable Responses With PD-1 Inhibition in Lung and Kidney Cancer and the Ongoing Search for Predictive Biomarkers.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJun 2015
300 _a1993-4 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
700 1 _aHammerman, Peter S
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 33
_gno. 18
_gp. 1993-4
856 4 0 _uhttps://doi.org/10.1200/JCO.2015.61.4172
_zAvailable from publisher's website
999 _c24847221
_d24847221